japan cross-border m&a - jp morgan · about j.p. morgan m&a advisory solutions 30 select...
TRANSCRIPT
Published by J.P. Morgan’s M&A team in June 2017
Japan
Koichiro Doi Head of Japan M&A E: [email protected] T: +813 6736 1861
Michiaki Maebori Executive Director, Japan M&A E: [email protected] T: +813 6736 9066
Global
Hernan Cristerna Global Co-Head of M&A E: [email protected] T: +44 20 7134 4631
Kurt Simon Global Chairman of M&A E: [email protected] T: +1 212 622 9882
Chris Ventresca Global Co-Head of M&A E: [email protected] T: +1 212 622 2228
North America
Anu Aiyengar Regional Head of M&A E: [email protected] T: +1 212 622 2260
Europe, Middle East and Africa
Dirk Albersmeier Regional Co-Head of M&A E: [email protected] T: +44 20 7742 4461
David Lomer Regional Co-Head of M&A E: [email protected] T: +44 20 7134 9798
Asia Pacific
Rohit Chatterji Regional Co-Head of M&A E: [email protected] T: +65 6882 2638
Kerwin Clayton Regional Co-Head of M&A E: [email protected] T: +852 2800 6555
Latin America
Ignacio Benito Regional Head of M&A E: [email protected] T: +1 212 622 2459
We thank John Hall, Co-Head of Global Investment Banking Coverage in Asia Pacific, for his contributions to this report.
JAPAN CROSS-BORDER M&A | 1
ContentsExecutive summary 2
1. Review of cross-border M&A (1980-2017) 3
2. Drivers of outbound M&A in Japan 5
3. Review of Japanese outbound and inbound M&A activity in 2015, 2016 and Q1 2017 15
4. Shareholder activism in Japan 23
5. Outlook for M&A activity in Japan 24
6. Considerations for international sellers and buyers 26
Key takeaways 29
About J.P. Morgan M&A advisory solutions 30
Select J.P. Morgan-advised Japan cross-border M&A transactions 31
Please note: Use of this material is subject to the important disclaimers set out on the inside back cover.
2 | JAPAN CROSS-BORDER M&A
Executive summary
Japanese M&A volume was strong in 2016, amounting to $198 billion in total transaction value, despite global geopolitical uncertainty. Cross-border M&A, in particular, was a bright spot for Japan, accounting for 57% of deals for the year, up from 45% in 2011. We anticipate continued interest on the part of corporate Japan to tap into international markets as companies search for growth. This report analyzes the main drivers behind the pickup — including demographic and economic trends affecting companies’ long-term growth plans — and why we anticipate the increase in cross-border M&A to be sustainable.
Key drivers of Japan cross-border M&A
• Shrinking population and slow domestic growth limit internal expansion.
• Corporate Japan’s mindset toward outbound M&A is changing.
• Enhancing growth, global competitiveness and market share requires outbound M&A.
• Funding cost remains low with near-zero interest rates and supportive bank lending.
• Government initiatives encourage outbound investment activity.
• Adoption of International Financial Reporting Standards (IFRS) is more conducive to M&A.
The report examines the impact of increased outbound M&A on a number of sectors and looks at the geographies that are most appealing to Japanese companies as they pursue outbound acquisitions. It also provides perspective on activism in Japan as an additional dimension of cross-border M&A.
The last section of this report identifies key considerations for potential international buyers and sellers as they formulate their M&A strategies and navigate the processes associated with deals with Japanese corporations.
JAPAN CROSS-BORDER M&A | 3
1. Review of cross-border M&A (1980-2017)
Meaningful cross-border M&A activity in Japan is a relatively recent phenomenon that began approximately six years ago. As seen in Exhibit 1, overall and cross-border M&A volume has occurred at three fundamentally different levels over the past 37 years. Cross-border volume did not occur consistently until 2006, while outbound volume increased significantly beginning in 2011. These trends reflect the continued slowdown of the Japanese economy, and Japanese corporations’ slowness to adapt to a changing global economy. In response, Japanese companies have had to forgo their traditionally domestic orientation and reliance on organic growth and acquire businesses abroad in search of growth.
Exhibit 1
Announced Japanese M&A transaction value (1980-2017E) and cross-border activity
1980
($bn)
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990 1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
E
250
150
50
0
100
200
300 Inbound deals % cross-border dealsDomestic deals Outbound deals
11
11
33
2
0.10.41.4
6
132
9
0.1273
0.32
0.4
13
113
0.1
34
8
224
38
25
1214
31
1011
317 15
77114
643
118
35%
32.5%
37.2%
26.4%
20.4%
20.4%
12.4%
29.3%
38%
49.5%
24.4%
35%
44.8%
55%
42.8%
52.1%
58.1%
56.8%
62.6%
77
16
25
124
85
55
98
134
269
218211 210
170
134
205215
142
130
195198
139
84
5341
78
107
236
16
17
12
52
154131
24
56
106
74
30
128
28
14
87
36
11
113
84
8
97
111
8
81
53
8
62
53
14
82
89
25
86
101
12
52
74
13
8
20
416
9
11
21
31
9
21
1344
640
32
81
Sources: Dealogic and Thomson One, as of March 31, 2017
4 | JAPAN CROSS-BORDER M&A
1980-1998This period is characterized by limited domestic and cross-border M&A volume, coinciding with a strong economy for Japan, which the rest of the world envied for its design and manufacturing acumen. In 1980, nearly half of the world’s 50 largest corporations by market capitalization were Japanese. M&A was not an element of corporate strategy as it was in the West, particularly in the U.S. and U.K.
There was a brief period of outbound activity in 1988 to 1990 that was generated by Japan’s robust economy, when corporations had excess cash to pay for foreign assets. Memorable transactions then included Mitsubishi Estate’s purchase of the landmark Rockefeller Center in New York City, Sony’s $3.4 billion acquisition of Columbia Pictures, Leyton House’s acquisition of a 54.5% stake in Hugo Boss in Germany and Asahi Breweries' acquisition of a 19.9% stake in Foster’s Brewing in Australia.
1999-2005This period witnessed an increase in overall M&A volume, including Japan’s record volume in 2005. Japanese activity was driven mainly by consolidation of domestic financial institutions, guided by the government to seek recovery from bad debts arising from the burst of the economic bubble in the early 1990s as well as continued lack of growth. Automotive companies consolidated alongside the global automotive industry. The two large deals in 2005 that accounted for the record volume were the $62 billion merger of Mitsubishi Tokyo Financial Group and UFJ Holdings and the $7.2 billion merger of Sankyo and Daiichi Pharmaceutical. Cross-border volume also increased markedly in this period and, unlike in later years, it was relatively balanced between inbound and outbound.
2006-present Beginning in 2006, Japan cross-border volume increased significantly in absolute size and as a share of overall M&A volume. Cross-border M&A increased to 29% of total volume in 2006 from a low point of 12% in 2005 and steadily climbed to 63% in the first quarter of 2017. This significant increase, specifically in outbound M&A, coincides with recognition of changing macroeconomic conditions in Japan. The growth of Japanese GDP 1996 to 2006 was almost flat, with a compound annual growth rate of 1%. In 2009, China’s economy overtook Japan’s in size; Japan became the world’s third-largest economy and witnessed its first drop in population. Flattening growth and a declining population altered business leaders’ outlook and encouraged Japanese corporations to pursue overseas acquisitions in search of new markets, capabilities and intellectual properties to enhance competitiveness and growth.
Three serial acquirers illustrate the increased dollar volume of outbound transactions in the technology, media and telecommunications (TMT), pharmaceutical and consumer sectors: SoftBank’s $36 billion acquisition of Sprint and $32 billion acquisition of ARM; Takeda’s $14 billion acquisition of Nycomed, $9 billion acquisition of Millennium and $5 billion acquisition of ARIAD; and Japan Tobacco’s $19 billion acquisition of Gallaher and $8 billion acquisition of R.J. Reynolds’ international tobacco business.
Section 2 of this report discusses key trends supporting the continuation of significant cross-border M&A, specifically outbound. Section 5 discusses likely future target sectors and geographic markets for cross-border M&A.
JAPAN CROSS-BORDER M&A | 5
2. Drivers of outbound M&A in Japan
Macro-economic backdrop: A shrinking population and slow-growing economy Japan’s declining population and slowing economy have created a sense of urgency among Japanese corporations to pursue outbound acquisitions to enter new markets, obtain new products and capabilities and access innovation.
The population of Japan reached its peak in 2008, at just over 128 million, and has declined in the years since, a trend that is anticipated to continue for the next four decades. Government-affiliated research released in April 2017 forecasts the population to shrink by an additional 16% to 108 million by 2040 and drop further by 33% to 88 million by 2060, despite the country’s goal to maintain a population of 100 million into the 2060s. Such a decline would further limit domestic organic expansion opportunities for Japanese corporations in the already saturated domestic market.
Exhibit 2
Population totals and forecast for Japan (mm)
88
126 127 127 128 128 128 128 128 127 126 125 124 123 122 120 119 117 115 114 112 110 108
130
120
100
90
80
1995 2000 2004 2008 2012 2016 2020 2024 2028 2032 2036 2040 2060
70
60
110
140
Source: National Institute of Population and Social Security Research (IPSS), as of March 31, 2017
In 2009, China overtook Japan as the world’s second-largest economy with double-digit GDP growth, a result of the mostly flat growth in Japan over the preceding decade. Japanese government projections forecast growth to remain anemic with a CAGR of 0.9% over the decade. According to IHS Global Insight, the Japanese economy may become the fourth largest by 2035 if the Indian economy continues its current trajectory.
6 | JAPAN CROSS-BORDER M&A
Exhibit 3
Historical and projected real GDP of Japan
30,000
25,000
1995 2000 2005 2010 2015 2020 2025 2030 204020350
15,000
20,000
10,000
5,000
Japan
($bn)
ChinaU.S. India
20352009
Sources: IHS Global insight and IPSS, as of March 31, 2017 Note: India GDP is converted to a calendar-year basis
Exhibit 4 Exhibit 5 Exhibit 6
Global GDP breakdown in 2000
Global GDP breakdown in 2017E
Global GDP breakdown in 2040E
Other31.9%
U.S.25.5%
Japan10.7%
Germany6.3%France
4.7%China4.5%
$50 trillion
U.K.4.2%
Brazil3.1%
Canada2.7%
Spain2.3%
Italy4.1%
Other34.7%
U.S.21.8%
China12.8%
Germany4.9%France
3.6%
Japan7.8%
$79 trillion
U.K.3.5%
Brazil2.9%India3.2%
Canada2.4%
Italy2.6%
Other34.5%
China19.4%
U.S.18.5%
Japan4.9%
Germany3.5%
India6.4%
$148 trillion
Brazil3.0%
U.K.2.9%
France2.6%
Canada2.0%
Indonesia2.2%
Source: IHS Global insight, as of March 31, 2017
JAPAN CROSS-BORDER M&A | 7
Change in mindset toward outbound M&AJapanese corporations have increasingly embraced outbound M&A to fund growth and advance their strategic objectives. As mentioned previously, they historically did not embrace M&A as a core element of their strategy. M&A was culturally challenging, given the perceived loss of face involved when selling a business. Even today, sales of businesses tend to occur primarily under duress, when companies have encountered financial distress or other fundamental challenges. Depending on the industry, the government might exert its influence to find suitable solutions. The mindset regarding acquiring international businesses has changed, as it has become necessary to enhance competitiveness and growth. The quality of a target’s management, its cultural affinity and its retention, however, remain important considerations.
Access to new markets, products and innovationJapanese corporations are increasingly looking beyond their borders to enter new markets, to obtain new products and capabilities, to access innovation to enhance their competitive positions in the global economy or to find new drivers of growth. The Japanese economy was the envy of the world in the 1980s, and Japanese corporations were the world’s leading manufacturers of consumer electronics, semiconductors, home appliances, automobiles and industrial products. However, in the 1990s, the corporations began to lose competitive ground globally because they did not adapt to a changing global economy as manufacturing moved to cheaper labor markets, new global supply chains were created and technology became an enabler of innovation, new products and greater productivity.
In contrast to 1990, when nearly 50% of top companies by market cap were Japanese, only one Japanese company is among the top 50 today. Approximately one-quarter of leading companies in the U.S. and Europe have remained in the top 50 since 1990. Among them, GE, IBM and P&G now have about five times their 1990 market value, demonstrating their success at adapting to a changing global economy and expanding over the years. Most Japanese firms only doubled in size in that time.
To regain global prominence with a shrinking domestic economy, Japanese corporations must acquire market share by entering new markets or expanding into new growth areas. Relying purely on in-house R&D and organic growth from the domestic market alone is clearly insufficient to achieve growth objectives. For this reason, many companies now seek to supplement internal efforts with M&A.
8 | JAPAN CROSS-BORDER M&A
Exhibit 7
Global ranking by market cap, as of January 1, 1990
Ranking Company Industry1 Country Mkt cap $bn
1 NTT Telecommunications Service Japan 159
2 ExxonMobil Energy U.S. 63
3 GE Industrial U.S. 58
4 TEPCO Energy Japan 56
5 IBM IT U.S. 54
6 Toyota Consumer Discretionary Japan 54
7 Royal Dutch Shell Energy Netherlands 53
8 Nomura HD Finance Japan 47
9 Bank of Japan Finance Japan 47
10 Altria Consumer Staples U.S. 39
11 Nippon Steel Industrials Japan 37
12 Panasonic Consumer Discretionary Japan 33
13 KEPCO Energy Japan 33
14 Hitachi Industrials Japan 32
15 Merck Healthcare U.S. 31
16 BT Group Telecommunications Service U.K. 30
17 BMS Healthcare U.S. 29
18 BP Energy U.K. 29
19 Dupont Materials U.S. 28
20 Toshiba Consumer Discretionary Japan 28
21 Mitsubishi Heavy Indus. Industrials Japan 27
22 Coca-Cola Consumer Staples U.S. 26
23 Nissan Consumer Discretionary Japan 26
24 Kawasaki Heavy Industry Industrials Japan 26
25 Walmart Consumer Staples U.S. 25
26 Chubu Electric Power Energy Japan 25
27 P&G Consumer Staples U.S. 24
28 Chevron Energy U.S. 23
29 Unilever Consumer Staples U.K. 23
30 Tokyo Gas Energy Japan 22
31 Verizon Telecommunications Service U.S. 22
32 Mitsubishi Estate Financials Japan 22
33 Mitsubishi Industrials Japan 22
34 Daiwa Securities Finance Japan 21
35 ANA Consumer Discretionary Japan 21
36 Ford Consumer Discretionary U.S. 21
37 British American Tobacco Consumer Staples U.K. 21
38 Tokyu Corporation Transportation Japan 20
39 Johnson & Johnson Healthcare U.S. 20
40 Sony Consumer Discretionary Japan 20
41 NEC Consumer Discretionary Japan 20
42 Asahi Glass Materials Japan 19
43 Dow Chemical Materials U.S. 19
44 AT&T Telecommunications Service U.S. 19
45 Eli Lilly Healthcare U.S. 19
46 GSK Healthcare U.K. 19
47 Fujitsu Consumer Discretionary Japan 19
48 3M Consumer Discretionary U.S. 18
49 GENERALI Insurance Italy 18
50 American International Insurance U.S. 17
Source: Thomson One, as of March 31, 2017 1 GICS industry classification
JAPAN CROSS-BORDER M&A | 9
Exhibit 8
Global ranking by market cap, as of January 1, 2017
Ranking Company Industry1 Country Mkt cap $bn
1 Apple IT U.S. 638
2 Alphabet IT U.S. 557
3 Microsoft IT U.S. 500
4 Berkshire Hathaway Finance U.S. 404
5 Amazon Consumer Discretionary U.S. 391
6 Facebook IT U.S. 376
7 ExxonMobil Energy U.S. 348
8 Johnson & Johnson Healthcare U.S. 308
9 JPMorgan Chase Finance U.S. 303
10 Wells Fargo Finance U.S. 283
11 Samsung IT Korea 265
12 GE Industrial U.S. 263
13 AT&T Telecommunications Service U.S. 259
14 Alibaba IT China 251
15 Tencent IT China 250
16 China Ind. & Comer. bank Finance China 234
17 China Mobile Telecommunications Service Hong Kong 232
18 BoAM Finance U.S. 228
19 Nestle Consumer Staples Swiss 226
20 P&G Consumer Staples U.S. 224
21 Royal Dutch Shell Energy Netherlands 223
22 PetroChina Company Energy China 221
23 Chevron Energy U.S. 210
24 Walmart Consumer Staples U.S. 205
25 Roche Healthcare Swiss 203
26 Verizon Telecommunications Service U.S. 200
27 Pfizer Healthcare U.S. 193
28 Visa IT U.S. 192
29 Novartis Healthcare Swiss 191
30 Bank of China Finance China 191
31 Toyota Automotive Japan 189
32 CCB Finance China 188
33 Comcast Consumer Discretionary U.S. 180
34 Coca-Cola Consumer Staples U.S. 179
35 Walt Disney Consumer Discretionary U.S. 175
36 Intel IT U.S. 174
37 Anheuser-Busch Consumer Staples Belgium 174
38 Merck Healthcare U.S. 171
39 HSBC Finance U.K. 168
40 Home Depot Consumer Staples U.S. 168
41 IBM IT U.S. 166
42 Oracle IT U.S. 165
43 Citi Group Finance U.S. 159
44 UHC Healthcare U.S. 154
45 Cisco Systems Telecommunications Service U.S. 154
46 TSMC Industrial Taiwan 154
47 Agricultural BOC Finance China 150
48 Philip Morris Consumer Staples U.S. 149
49 Pepsi Consumer Staples U.S. 149
50 Altria Consumer Staples U.S. 139
Source: Thomson One, as of March 31, 2017 1 GICS industry classification
10 | JAPAN CROSS-BORDER M&A
Supportive financing environmentClose-to-zero interest rates
The Bank of Japan has implemented a number of monetary easing policies with the objective of lowering borrowing costs for Japanese corporations, to encourage expansion of investments. The 10-year and 30-year Japanese government bond interest rates have remained low compared with rates in the U.S. and the EU. In January 2016, the Bank of Japan announced it would push interest rates below zero after years of keeping them low but positive. Currently, rates are slightly above zero, and any additional reduction in the rates would cause real interest rates to fall further, providing more favorable financing sources for Japanese corporations.
Exhibit 9
Interest rate on 10-year government bonds
10%
8%
1995 1997 1999 2001 2003 2006 2008 2010 20172012 2015-2%
4%
6%
2%
0%
EUJapan ChinaU.S.
3.293%
2.377%
0.344%0.058%
Source: Bloomberg, as of March 31, 2017
10 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 11
Main bank system
Japanese corporations are supported by a banking system, referred to as the “main bank” system, under which corporations are closely connected to their primary lending banks. Usually, main banks can lend to their key customers at extremely low rates, with less rigid covenant terms and more favorable leverage levels.
For Nikkei 225 Japanese corporations, bank borrowings represent 73% of total outstanding debt, while the main source of debt financing for U.S. companies listed on the New York Stock Exchange (NYSE) is bonds.
Exhibit 10 Exhibit 11
Bank and bond debt as % of total debt (Nikkei 225 Japanese companies)
Bank and bond debt as % of total debt (U.S. companies listed on NYSE)
Bonds27%
Bankborrowings
73%
Bonds65%
Other debt35%
Sources: Nikkei FQ and Factset, as of March 31, 2017
12 | JAPAN CROSS-BORDER M&A
Supportive political environmentOver the past decade, the Japanese government has introduced a number of initiatives and policies to support strategic investments, both domestically and overseas. The Development Bank of Japan (DBJ), the Innovation Network Corporation of Japan (INCJ) and the Japan Bank for International Cooperation (JBIC) are government-owned financial institutions whose mandate is to encourage and support Japanese corporations in their pursuit of cross-border investments, providing various financing options and expertise both before and after the acquisition.
DBJ DBJ is owned by the Japanese Ministry of Finance. It provides numerous financial services, including financing, co-investing and advisory services, to help Japanese corporations expand their businesses and achieve their strategic goals, such as acquiring overseas companies.
Illustrative transaction
DBJ’s and LIXIL’s $3.8 billion acquisition of GROHE Group
DBJ’s role
DBJ and LIXIL acquired an 87.5% equity interest in GROHE Group through a 50-50 joint venture. DBJ provided financial support for the acquisition and supplementary resources such as expertise, personnel and domestic and international information networks to help GROHE reinforce its competitiveness and LIXIL to enhance the value of its entire corporate group.
Transaction rationale
LIXIL is a Japanese building materials manufacturer, and its acquisition of GROHE Group, a German sanitary fittings manufacturer, significantly increased LIXIL’s footprint in Europe and helped it to expand in China through GROHE’s bathroom fittings unit, which sells through more than 4,000 distributors in Asia’s largest economy.
Sources: DBJ HP, accessed on March 31, 2017; Dealogic, as of March 31, 2017; press release
12 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 13
INCJINCJ, launched in July 2009, is a unique public-private partnership aimed at promoting innovation and enhancing the value of businesses in Japan. It has an investment capability of approximately $18 billion.
Illustrative transaction
Toshiba’s $2.3 billion acquisition of Landis & Gyr
INCJ’s role
The transaction was the largest joint investment in INCJ history. INCJ invested $920 million for a 40% stake in Landis & Gyr.
Transaction rationale
Toshiba manufactures advanced electronic and electrical products, and its acquisition of Landis & Gyr, the leading global provider of electricity metering and smart grid solutions, served as the foundation for Toshiba’s Smart Community platform. It established Toshiba as a niche market leader in the global smart grid and advanced metering industries.
Sources: INCJ HP, accessed on March 31, 2017; Dealogic, as of March 31, 2017; press release
JBIC JBIC is a Japanese policy-based financial institution that provides loans, equity investments and guarantees. JBIC provides overseas investment loans to Japanese companies, overseas Japanese affiliates (including joint ventures) and foreign governments or financial institutions that are investing in or providing loans to Japanese business.
Illustrative transaction
Daikin Industries’ $3.7 billion acquisition of Goodman Global Group
JBIC’s role
JBIC provided a $1.5 billion loan to support Daikin in financing its acquisition of Goodman Global Group.
Transaction rationale
Daikin Industries is a global leader in commercial and industrial air conditioning system solutions, and its acquisition of Goodman Global Group, a leading North American manufacturer of heating, ventilation and cooling systems (HVAC), enabled Daikin to access the U.S. residential and commercial HVAC markets and to launch advanced, environmentally friendly products to expand its existing business.
Sources: JBIC HP, accessed on March 31, 2017; Dealogic, as of March 31, 2017; press release
14 | JAPAN CROSS-BORDER M&A
Adoption of IFRS is more conducive to M&AJapanese corporations have traditionally applied J-GAAP accounting methods. However, the number of companies shifting to IFRS is increasing. One of the reasons for this is to make overseas acquisitions easier to execute from an accounting perspective. Under traditional Japanese standards, goodwill generated in acquisitions must be amortized every year, which dilutes post-acquisition earnings per share (EPS) even for all-cash transactions. Under IFRS, goodwill is no longer amortized and, as a result, improves the pro forma earnings.
Currently, 111 Japanese corporations report under IFRS and 32 have announced their intentions to convert to IFRS. Among the Nikkei 225 companies, 23% have converted to IFRS. Most of these companies are large Japanese corporations that have executed many of the largest outbound transactions over the past 10 years.
Exhibit 12
Select examples of Japanese corporations reporting under IFRS and their completed outbound acquisitionsCompany IFRS conversion date Select large outbound transactions
SoftBank Group Corp. March 2014 Acquisition of Sprint ($36.1bn, October 2012) ARM ($31.8bn, July 2016)
Japan Tobacco Inc. March 2012 Acquisition of Gallaher Group plc ($19bn, December 2006) R.J. Reynolds International ($8bn, March 1999)
Takeda Pharmaceutical Co Ltd. March 2014 Acquisition of Nycomed ($13.7bn, May 2011) Millennium ($8.8bn, April 2008) ARIAD ($5.2bn, January 2017)
Itochu Corp. March 2014 Investment in CITIC ($10.4bn, January 2015)
Asahi Group Holdings Ltd. March 2017 Acquisition of SAB Miller ($7.8bn, December 2016)
Dentsu Inc. March 2015 Acquisition of Aegis Group plc ($4.9bn, July 2012)
Marubeni Corp. March 2013 Acquisition of Gavilon Group LLC ($4.7bn, May 2012)
Astellas Pharma Inc. March 2014 Acquisition of OSI Pharmaceuticals Inc ($4bn, March 2010)
Sources: Japan Exchange Group and Dealogic, as of March 31, 2017
At the same time, companies remain cautious because IFRS requires companies to report goodwill impairments when the value of a purchased asset falls below the value paid at the time of the acquisition.
14 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 15
3. Review of Japanese outbound and inbound M&A activity in 2015, 2016 and Q1 2017
Outbound M&A2015
Outbound M&A volume in 2015 was $89 billion, which represented 45% of total M&A volume that year. Japanese insurers were the leading acquirers of overseas business in 2015 and were responsible for seven of the top 10 deals by deal value. The outbound volume by insurance companies totaled $24.3 billion, 27% of total outbound volume.
Exhibit 13
Top five outbound transactions by deal value in 2015
Announcement date
Target Target country
Target general industry group
Acquirer Deal value ($bn)
Acquired stake %
Jan. 20 CITIC Ltd. China Holding Companies
Itochu Corp; Charoen
Pokphand Group Co Ltd.
10.4 19.7
June 10 HCC Insurance Holdings Inc. U.S. Insurance Tokio Marine Holdings
7.5 100
Feb. 18 Toll Holdings Ltd. Australia Transportation Japan Post Holdings
6.4 100
Sept. 8 Amlin Plc U.K. Insurance MS&AD Insurance Group
5.3 100
Sept. 29 Reynolds American Inc. (Natural American Spirit
business)
U.S. Consumer Products
Japan Tobacco Inc.
5.0 100
Source: Dealogic, as of March 31, 2017
Exhibit 14
Deal value in 2015
Holding Companies 11%
Other 37%
Computers & Electronics 8% Finance 10%
Transportation 9%
Insurance 26%
Source: Dealogic, as of March 31, 2017 Note: Numbers may not sum due to rounding
16 | JAPAN CROSS-BORDER M&A
Illustrative transaction
J.P. Morgan acted as a financial advisor on the following illustrative transaction:
Reynolds American’s $5 billion sale of its Natural American Spirit international business to Japan Tobacco
Transaction rationale
The transaction strengthened the revenue growth of Japan Tobacco by adding a premium brand that is widely recognized in the domestic market to its portfolio.
2016
Last year produced the second-highest volume ever of outbound M&A by Japanese corporations. Outbound M&A totaled $101 billion — 51% of total M&A volume in 2016 and a 13% increase from 2015. Targeted assets were more diversified, including computers and electronics, food and beverage, healthcare, machinery and insurance.
Exhibit 15
Top five outbound transactions by deal value in 2016
Announcement date
Target Target country
Target general industry group
Acquirer Deal value ($bn)
Acquired stake %
July 18 ARM Holdings Plc U.K. Computers & Electronics
SoftBank Group Corp.
31.8 98.6
Dec. 13 SABMiller Ltd. (CEE beer brands)
Czech Republic
Food & Beverage
Asahi Group Holdings Ltd.
7.8 100
Sept. 13 Intersil Corp. U.S. Computers & Electronics
INCJ/Renesas 3.2 100
Mar. 28 Dell Systems; Dell Services; Dell Technology & Solutions
U.S. Computers & Electronics
NTT Group 3.1 100
Feb. 10 Birra Peroni Srl; Koninklijke Grolsch NV; Miller Brands UK Ltd.;
Meantime Brewing
Italy Food & Beverage
Asahi Group Holdings Ltd.
2.9 100
Source: Dealogic, as of March 31, 2017
Exhibit 16
Deal value in 2016
Food & Beverage 13%
Other 26%
Insurance 6%
Healthcare 7%
Machinery 7%
Computers & Electronics 41%
Source: Dealogic, as of March 31, 2017
16 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 17
Illustrative transactions
J.P. Morgan acted as a financial advisor on the following illustrative transactions:
Intersil’s $3.2 billion sale to Renesas
Transaction rationale
The acquisition created a highly synergistic, complementary product portfolio of system solutions targeted at large opportunities in the automotive, industrial and internet of things (IoT) markets.
NTT DATA’s $3.1 billion acquisition of Dell Services
Transaction rationale
The deal was a transformational acquisition for NTT DATA (largest M&A deal in its corporate history), significantly increasing NTT DATA’s presence in North America and strengthening its global delivery network.
Q1 2017
Outbound M&A volume in the first quarter was $18 billion, 53% of total Q1 M&A volume. Extrapolating the full-year volume from the first quarter results in a total outbound volume of $74 billion (provided there is no cyclicality). The majority of activity in Q1 was in the healthcare and real estate sectors. The two largest transactions were Takeda Pharmaceutical’s $5.7 billion acquisition of ARIAD Pharmaceuticals and SoftBank Group’s $3.3 billion acquisition of Fortress Investment Group.
Exhibit 17
Top five outbound transactions by deal value in Q1 2017
Announcement date
Target Target country
Target general industry group
Acquirer Deal value ($bn)
Acquired stake %
Jan. 9 Ariad Pharmaceuticals Inc.
U.S. Healthcare Takeda Pharmaceutical
Co Ltd.
5.7 100
Feb. 14 Fortress Investment Group LLC
U.S. Finance SoftBank Group Corp.
3.3 100
Jan. 30 WeWork Companies Inc. U.S. Real Estate SoftBank Group Corp.
3.0 Undisclosed
Feb. 28 Intelsat SA U.S. Telecom- munications
SoftBank Group Corp.
1.7 39.9
Mar. 23 Vanderlande Industries BV
Netherlands Machinery Toyota Industries Corp.
1.3 100
Source: Dealogic, as of March 31, 2017
18 | JAPAN CROSS-BORDER M&A
Exhibit 18
Deal value in Q1 2017
Real Estate 19%
Other 14%
Machinery 7%
Finance 18%
Telecommunications 9%
Healthcare 33%
Source: Dealogic, as of March 31, 2017
Illustrative transactions
J.P. Morgan acted as a financial advisor on the following illustrative transactions:
ARIAD Pharmaceuticals’ $5.7 billion sale to Takeda Pharmaceutical
Transaction rationale
Allows ARIAD to accelerate its discovery, development and delivery of precision therapies to patients with rare cancers by combining Takeda’s global resources with ARIAD’s products, pipeline and people. Creates a stronger global solid tumor franchise, positioning the combined company for sustainable long-term growth in oncology.
SoftBank Group’s $3.3 billion acquisition of Fortress Investment Group
Transaction rationale
SoftBank’s acquisition of Fortress Investment Group combines SoftBank’s leading global technology investing capabilities, alongside its SoftBank Vision Fund, with Fortress’ private equity and credit investing expertise.
18 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 19
Inbound M&A2015
Inbound M&A volume totaled $25 billion and represented 22% of cross-border and 12.8% of total M&A volume in 2015. The year was highlighted by one large transportation transaction and a number of healthcare transactions. The primary driver of inbound M&A was the sale of non-core assets by Japanese pharmaceuticals to reorganize their business portfolios to focus more on R&D in specific therapeutic areas. Sales of non-core assets by Astellas and Takeda ranked as the fourth- and fifth-largest deals, as shown in the table below. The other transactions were mainly acquisitions of real estate assets by foreign companies.
Exhibit 19
Top five inbound transactions by deal value in 2015
Announcement date
Target Target sector
Acquirer Acquirer region Deal value ($bn)
Acquired stake %
Nov. 10 New Kansai International Airport Co Ltd.
Transportation VINCI SA; ORIX Corp.
Europe 13.6 100
Sept. 28 USJ Co Ltd. Leisure & Recreation
Comcast Corp. North America 4.9 51
Jan. 30 Meguro Gajoen Co Ltd. Real Estate LaSalle Investment
Management Inc.
North America 1.2 100
Nov. 11 Astellas Pharma Inc. (global dermatology business
including Protopic, except for Protopic in Japan)
Healthcare Leo Pharma A/S
Europe 0.7 100
Dec. 16 Takeda Pharmaceutical Co Ltd. (respiratory business)
Healthcare AstraZeneca Plc
Europe 0.6 100
Source: Dealogic, as of March 31, 2017
Exhibit 20
Deal value in 2015
Leisure & Recreation 20%
Other 2%Computers & Electronics 4%
Healthcare 11%
Real Estate 9%
Transportation 54%
Source: Dealogic, as of March 31, 2017
20 | JAPAN CROSS-BORDER M&A
Illustrative transaction
J.P. Morgan acted as a financial advisor on the following illustrative transaction:
LEO Pharma’s $725 million acquisition of Astellas’ dermatology portfolio
Transaction rationale
The dermatology portfolio was a strong strategic fit with LEO Pharma’s focus areas of prescription topical drugs for eczema, acne and skin infections; strengthened the company’s global position in dermatology in China and Russia; and added critical scale in many other markets.
2016
Inbound transaction volume totaled $12 billion, representing 10.4% of cross-border and 5.9% of total M&A volume in 2016. Hon Hai Precision Industry acquired Sharp Corp. in pursuit of synergies between Hon Hai’s global production and marketing system and Sharp’s advanced R&D capability. The deal marked one of the largest inbound acquisitions in history. Qualcomm’s forming a joint venture with TDK is another example of technological collaboration that enables Qualcomm’s RFFE business unit to deliver RF front-end modules and RF filters in a fully integrated system for mobile devices and fast-growing business segments such as IoT, automotive applications and connected computing. A number of transactions took place in the healthcare sector, including Novartis’ sale of 14 prescription brands in Japan to Sun Pharmaceutical and Shionogi’s sale of 21 off-patent products to Lupin.
Exhibit 21
Top five inbound transactions by deal value in 2016
Announcement date
Target Target sector
Acquirer Acquirer region Deal value ($bn)
Acquired stake %
Feb. 25 Sharp Corp. Consumer Electronics
Hon Hai Precision
Industry; SIO International (57.5%/8.41%)
North Asia 7.9 66.06
Jan. 13 TDK Corp. (RF component supply division)
Computers & Electronics
Qualcomm Inc. North America 1.4 51
Mar. 17 Toshiba Lifestyle Products & Services Corp.
Consumer Electronics
Midea Group Co Ltd.
North Asia 0.5 80.1
Mar. 29 Novartis Pharma Co Ltd. (14 prescription brands
in Japan)
Healthcare Sun Pharmaceutical Industries Ltd.
Indian subcontinent
0.3 100
May 26 Carna Biosciences Inc. (worldwide rights to
develop and commercialize cancer drug candidate AS-141 targeting CDC7)
Healthcare ProNAi Therapeutics
Inc.
North America 0.3 100
Source: Dealogic, as of March 31, 2017
20 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 21
Exhibit 22
Deal value in 2016
Computers & Electronics 14%
Other 3%Real Estate 2%
Healthcare 6%Auto/Truck 2%
Consumer Electronics 73%
Source: Dealogic, as of March 31, 2017
Illustrative transaction
J.P. Morgan acted as a financial advisor on the following illustrative transaction:
Hon Hai Precision Industry’s $3.5 billion acquisition of Sharp Corp.
Transaction rationale
Gaining capital from Hon Hai provided Sharp with sufficient resources to develop OLED display as a next-generation display product. Hon Hai will obtain access to Sharp’s brand and broad IP portfolio, shifting its business upstream in the value chain.
22 | JAPAN CROSS-BORDER M&A
Q1 2017
Q1 2017 inbound M&A volume totaled $3.2 billion — 14.9% of cross-border and 9.3% of total Q1 M&A volume. Extrapolating the full-year volume from the first quarter results in a total inbound volume of $13 billion (provided there is no cyclicality). In Q1 2017, Comcast announced its intention to acquire the remaining 49% stake in USJ. The acquisition aims to align USJ with Comcast’s ongoing investment strategy for its theme parks, including plans to open major attractions based on its blockbuster film franchises and other world-class intellectual property (IP) to boost attendance and revenue. Several asset acquisitions by overseas REITs and real estate investment firms also took place in Q1 2017.
Exhibit 23
Top five inbound transactions by deal value in Q1 2017
Announcement date
Target Target sector
Acquirer Acquirer region Deal value ($bn)
Acquired stake %
Feb. 28 USJ Co Ltd. Leisure & Recreation
Comcast Corp. North America 2.3 49
Feb. 20 Four shopping centers Real Estate CapitaLand Ltd. Southeast Asia 0.4 100
Mar. 27 INPEX Natuna Ltd. Oil & Gas Encore Ltd. Southeast Asia 0.2 100
Feb. 2 Oki Sensor Device Corp. Computers & Electronics
Standex International
Corp.
North America 0.1 100
Jan. 18 Property Portfolio (Kinshicho Prime Tower)
Real Estate Invesco Ltd. North America 0.1 100
Source: Dealogic, as of March 31, 2017
Exhibit 24
Deal value in Q1 2017
Other 0.5%Dining & Lodging 1%
Real Estate 20%
Computers & Electronics 6%
Oil & Gas 5%
Leisure & Recreation 68%
Source: Dealogic, as of March 31, 2017 Note: Numbers may not sum due to rounding
22 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 23
4. Shareholder activism in Japan
Activism is one dimension of cross-border M&A activity. Japan has historically been one of the most targeted geographies outside the U.S. and has, along with some of the other more mature economies in the region, accounted for the bulk of activity in Asia. In 2016, 18 activist campaigns launched against Japanese companies, representing 20% of all activism activity in the region for the year.
Most campaigns to date have been launched by domestic investors. Asia-based funds account for 58% of all activism activity in Asia and 54% in Japan since 2011.1 However, some of the world’s most aggressive activist funds, including The Children’s Investment Fund and most recently Third Point, have targeted Japanese companies with demands mostly centered on value, ranging from return of capital to shareholders to portfolio streamlining and optimization.
Recent regulatory reform in Japan has further legitimized shareholder activism. Japan’s Corporate Governance and Stewardship codes aim to shake up companies by shining a spotlight on board independence and by empowering investors to be more active by increasing engagement with portfolio companies and seeking higher returns. Investors have already begun capitalizing on the heightened interest in corporate governance, denouncing companies that act against the fundamental principles established by the Corporate Governance Code.
Activists have recently been credited with pushing companies toward shifts in strategy, return of capital to shareholders, improvement of investor communications and renouncing nepotism. Even though shareholder activism in Japan has not yet experienced the level of success the strategy has had in the U.S., recent high-profile wins signal a changing attitude in both the investors, who have become more assertive, and the companies, many of which have proved increasingly open to outside intervention.
As is the case with investor activism outside the U.S., activism in Japan is expected to continue to increase and become a fixture in the Japanese financial market.
1 SharkRepellent, Activist Insight, Mergermarket, press articles as of April 18, 2017. Represents the following campaign types: board control and representation, enhance corporate governance, maximize shareholder value, remove director(s), remove officer(s) and vote/activism against a merger.
24 | JAPAN CROSS-BORDER M&A
5. Outlook for M&A activity in Japan
Outbound M&A Japanese corporations will continue to pursue overseas acquisitions with support from the government and banks.
Target sectors Consumer
Domestic markets are heavily affected by the shrinking population, and companies will seek to increase market share in a growing global economy.
Precedent transactions:
• Japan Tobacco’s $19 billion acquisition of Gallaher Group
• Suntory’s $16 billion acquisition of Beam
• Asahi Group’s $7.8 billion acquisition of SAB Miller
Financial institutions/Insurance
Similar to the consumer sector, financial institutions and insurers are also directly affected by the aging population of Japan and will continue to make outbound acquisitions.
Precedent transactions:
• Tokio Marine Holdings’ $7.5 billion acquisition of HCC Insurance
• Japan Post Holdings’ $6.4 billion acquisition of Toll Holdings
• MS&AD Insurance Group’s $5.3 billion acquisition of Amlin plc
• Meiji Yasuda Life Insurance’s $5 billion acquisition of StanCorp Financial Group
Healthcare
In 2015, Japan’s Ministry of Health, Welfare and Labor announced a comprehensive strategy to strengthen the pharmaceutical industry. The strategy promotes expansion of healthcare businesses through outbound M&A.
Precedent transactions:
• Takeda’s $13.7 billion acquisition of Nycomed, $8.8 billion acquisition of Millennium and $5.7 billion acquisition of ARIAD
• Astellas’ $4.1 billion acquisition of OSI Pharmaceuticals
Technology
Japanese companies will continue to gain access to additional intellectual property, capabilities and innovation through outbound acquisitions.
Precedent transactions:
• NTT DATA’s $3.1 billion acquisition of Dell Services
• Renesas’ $3.2 billion acquisition of Intersil
Source: Dealogic, as of March 31, 2017
24 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 25
Target geographiesOutbound M&A is expected to be directed primarily to the U.S. and Europe, although some activity is likely in emerging markets such as Southeast Asia. Japanese corporations are looking for mature companies with stable cash flow, strong brand recognition and access to a large, growing market.
Potential risks could limit outbound activity. They include asset price inflation, risk of goodwill impairments under IFRS and uncertainties associated with post-acquisition integration.
Inbound M&AInbound M&A is expected to be a small percentage of overall cross-border activity. Historically, such activity has been limited to distressed situations such as Hon Hai’s acquisition of Sharp Corp. However, Japanese corporations, in pursuit of corporate clarity, may seek to divest non-core assets. Rationalization of business portfolios will provide buy-side opportunities for foreign corporations as well as domestic and foreign private equity firms. It will likely begin with previously acquired overseas assets and subsidiaries before considering domestic subsidiaries or business units.
26 | JAPAN CROSS-BORDER M&A
6. Considerations for international sellers and buyers
Based on J.P. Morgan’s experience advising Japanese counterparties, we have identified points for consideration by international companies seeking to either sell to Japanese buyers or acquire Japanese assets.
Considerations for international sellersAttractive acquirers
Motivated buyers:
Given the realities of the domestic economy and the imperative to expand overseas and gain access to new markets, know-how, new products and intellectual property, Japanese corporations are highly motivated buyers. Generally, if they indicate an interest or participate in an auction, they have done work analyzing the opportunity and have built a preliminary consensus internally to support the company’s pursuit of the acquisition.
Valuation:
Similar to other Asian companies, Japanese acquirers have the capacity to be aggressive on value and to find value in synergies and share that value with the seller. In addition, Japanese corporations are more focused on long-term returns and, compared with international companies, they have relatively low hurdle rates and high debt capacity, which allow them to be aggressive on value.
Financing:
Low-cost debt and government financing support, as discussed in Section 2, enable Japanese corporations to be aggressive on price if they are highly motivated buyers. Japanese banks allow higher debt leverage levels than international banks.
Process expertise:
Many Japanese companies have had experience acquiring businesses overseas, specifically in the U.S. and Europe, and they know how auction processes work. Despite the need to account for buyers managing their internal approval processes and possibly providing additional access before or during the process, Japanese buyers generally keep to the process timeline and compete aggressively with other buyers.
26 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 27
Building in extra time for Japanese buyers
Internal approvals:
Many Japanese companies have formal internal, consensus-driven approval processes and spend time socializing ideas with their board members, educating them on the potential target during the due diligence process. These internal meetings have rigid timelines and dates set far in advance. Ad hoc board meetings are uncommon in Japan; however, Japanese companies have demonstrated the ability to meet accelerated timelines during competitive auctions, if motivated.
Relationship building:
International sellers should plan their process timelines to include both pre-marketing and relationship building with Japanese buyers before launching a formal process. Culturally, there is an emphasis on in-person meetings, which requires additional time for international sellers. Language barriers, cultural differences and multiple time zones should be taken into account when creating a realistic timeline for sale processes involving Japanese buyers.
Due diligence:
During the due diligence process, Japanese buyers often wish to spend time with a target company’s management team to educate themselves on the business and sector, assess the management capabilities and determine whether the team in place can be relied upon to manage the business after the acquisition. In many cases, retention of the current management team is a priority for Japanese buyers so a target company’s management should plan to allocate time for face-to-face meetings with Japanese buyers.
Considerations for international buyersCommunication with the Japanese government:
Close communication with the Japanese government is required as it adopts a conservative stance on selling to foreign buyers’ businesses that are considered significant to supporting the Japanese economy. In addition, approval from the Ministry of Economy, Trade and Industry is required when acquiring companies that make products related to national security and aerospace. Government filing requirements may be triggered depending on the size, form and substance of the deal.
Post-acquisition employment:
International buyers often plan to reduce headcount at the target company to improve cost margins. However, both cultural and legal protections for employees exist in Japan, and the standards for termination of redundant employees are difficult for an acquirer. International buyers need to address the concern of post-acquisition employment when communicating with Japanese management teams.
28 | JAPAN CROSS-BORDER M&A
Fiduciary duty:
Unlike U.S. companies, directors of Japanese corporates do not have a direct fiduciary duty to shareholders. When making an offer to a Japanese corporation, the target’s board will make a decision based on its interpretation of the best interests of the company’s stakeholders, which include shareholders, employees, customers, lenders and other constituencies. Therefore, value maximization for shareholders is not the only factor that the board will consider when an offer is received. This is one of the reasons that unsolicited transactions are rare and mostly unsuccessful in Japan.
Shareholders:
Even after the Corporate Governance Code was introduced in 2015, a material portion of public companies’ shares remain owned by “friendly shareholders,” and in many cases they own each other’s shares. These cross-shareholdings enable boards to maintain their position and allow them to focus on long-term strategy. Furthermore, a significant portion of the shares are held by retail investors who might not make economically rational decisions if they have a strong attachment to the company’s brand and products. These are additional reasons that unsolicited transactions have been unsuccessful in Japan.
28 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 29
Key takeaways
The recent substantial increase in Japan cross-border M&A activity will be sustained by the need for Japanese corporations to increase growth they are unable to generate domestically. In doing so, they will continue to use cross-border acquisitions to enter new markets, obtain new products and capabilities and access innovation to enhance global competitiveness and market share.
Outbound M&A activity will likely focus on the consumer, financial institutions, healthcare and technology sectors, with the U.S., Europe and South Asia as the primary target markets. For international companies, Japanese corporations are attractive buyers because they generally are motivated, experienced in auction processes and can be aggressive on value. From a process perspective, however, sellers should remain aware of the need to build in extra time to enable Japanese buyers to obtain internal approvals, complete due diligence and engage in relationship building.
Increased divestiture of non-core assets by Japanese conglomerates in the future will provide additional inbound M&A opportunities for international buyers. Buyers should closely communicate with the Japanese government and remain mindful of post-acquisition employment considerations and different shareholder dynamics in Japan.
30 | JAPAN CROSS-BORDER M&A
About J.P. Morgan M&A advisory solutions
We advise corporations and institutions of all sizes on their most complex strategic needs, in their home markets and around the world. Whatever your strategic challenge or opportunity, J.P. Morgan provides a full M&A offering to address your needs. Drawing upon our in-depth industry-specific expertise and regional market acumen, we can evaluate your business with a long-term view to provide a tailored, comprehensive and integrated solution.
We have a track record of strategic defense. Our scale and breadth of experience with shareholder activism mean we provide a differentiated approach toward defense for clients. We have successfully engaged with all the major activists in some of the most sophisticated campaigns around the world, and our deep understanding of activist tactics and firsthand knowledge bring experience to your defense. As we advise only corporate clients and do not counsel any shareholder activist campaigns, our interests are fully aligned with your company’s priorities.
Clients benefit from J.P. Morgan’s global experience leveraging our specialized advice, swift strategic execution and strong resources to help you seize opportunities and solve problems.
Our bespoke solutions combine:
• In-depth knowledge of sector and market dynamics with M&A bankers based locally in most major markets globally.
• Innovative advice on valuation, transaction structures, and deal tactics and negotiations.
• Rigorous execution delivered with responsive and agile service.
• Ability to partner with product experts across our full range of competencies, including comprehensive financing through our debt and equity issuance platforms, as well as derivatives and treasury services, such as escrow services.
J.P. Morgan provides M&A advisory solutions across the full strategic life cycle of our clients:
Strategic expansion
• Acquisitions, including cross-border opportunities
• Mergers and joint ventures
Enhancing business value
• Corporate combinations
• Divestures
• Capital restructuring projects
• Spinoffs and other repositionings
Shareholder strategy
• Defense preparations for publicly announced and non-public approaches
• Dedicated shareholder activism advice
30 | JAPAN CROSS-BORDER M&A JAPAN CROSS-BORDER M&A | 31
Select J.P. Morgan-advised Japan cross-border M&A transactions
Jan 2017 $5.7bn
Advisor to ARIAD Pharmaceuticals on its sale to Takeda Pharmaceutical
Sep 2015 $5.0bn
Advisor to Reynolds American on its sale of Natural American Spirit International business to Japan Tobacco
Feb 2016 $3.5bn
Advisor to Hon Hai Precision Industry on its acquisition of Sharp Corporation
Sep 2016 $3.2bn
Advisor to Intersil on its sale to Renesas
Mar 2016 $3.1bn
Advisor to NTT DATA on its acquisition of Dell Services
Oct 2016 $1.4bn
Advisor to Ganymed on its sale to Astellas Pharma
Jan 2015 $840mm
Advisor to Itochu on its sale of PrimeSource Building Products to Platinum Equity
Mar 2015 $550mm
Advisor to Nippon Yusen Kabushiki Kaisha on its sale of Crystal Cruises to Genting HK
Nov 2015 $725mm
Advisor to LEO Pharma on its acquisition of Astellas’ dermatology portfolio
June 2016 $380mm
Advisor to Sequent Medical on its sale to Terumo
Dec 2016 $510mm
Advisor to Asahi Glass on its acquisition of CMC Biologics
Oct 2016 $500mm
Advisor to Asahi Glass on its acquisition of Vinythai
July 2016 $733mm
Advisor to Nichi-Iko on its acquisition of Sagent Pharmaceuticals
Feb 2017 $3.3bn
Advisor to SoftBank on its acquisition of Fortress Investment Group
Dec 2016 $925mm
Advisor to Sumitomo Corporation on its acquisition of Fyffes
Oct 2015 $498mm
Advisor to Mitsui Gás e Energia do Brasil on its acquisition of 49% stake in Gaspetro from Petrobras
32 | JAPAN CROSS-BORDER M&A
This material (including market commentary, market data, observations or the like) has been prepared by personnel in the Mergers & Acquisitions Group of JPMorgan Chase & Co. It has not been reviewed, endorsed or otherwise approved by, and is not a work product of, any research department of JPMorgan Chase & Co. and/or its affiliates (“J.P. Morgan”). Any views or opinions expressed herein are solely those of the individual authors and may differ from the views and opinions expressed by other departments or divisions of J.P. Morgan. This material is for the general information of our clients only and is a “solicitation” only as that term is used within CFTC Rule 1.71 and 23.605 promulgated under the U.S. Commodity Exchange Act.
RESTRICTED DISTRIBUTION: This material is distributed by the relevant J.P. Morgan entities that possess the necessary licenses to distribute the material in the respective countries. This material is proprietary and confidential to J.P. Morgan and is for your personal use only. Any distribution, copy, reprints and/or forward to others is strictly prohibited.
This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute investment, legal or tax advice, nor does it constitute an offer or solicitation for the purchase or sale of any financial instrument or a recommendation for any investment product or strategy.
Information contained in this material has been obtained from sources believed to be reliable but no representation or warranty is made by J.P. Morgan as to the quality, completeness, accuracy, fitness for a particular purpose or non infringement of such information. In no event shall J.P. Morgan be liable (whether in contract, tort, equity or otherwise) for any use by any party of, for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you in evaluating the merits of participating in any transaction. All information contained herein is as of the date referenced and is subject to change without notice. All market statistics are based on announced transactions. Numbers in various tables may not sum due to rounding.
J.P. Morgan may have positions (long or short), effect transactions, or make markets in securities or financial instruments mentioned herein (or options with respect thereto), or provide advice or loans to, or participate in the underwriting or restructuring of the obligations of, issuers mentioned herein. All transactions presented herein are for illustration purposes only. J.P. Morgan does not make representations or warranties as to the legal, tax, credit, or accounting treatment of any such transactions, or any other effects similar transactions may have on you or your affiliates. You should consult with your own advisors as to such matters.
The use of any third-party trademarks or brand names is for informational purposes only and does not imply an endorsement by JPMorgan Chase & Co. or that such trademark owner has authorized JPMorgan Chase & Co. to promote its products or services.
J.P. Morgan is the marketing name for the investment banking activities of JPMorgan Chase Bank, N.A., J.P. Morgan Limited, J.P. Morgan Securities LLC (member, NYSE), J.P. Morgan Securities plc (authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority), J.P. Morgan Australia Limited (ABN 52 002 888 011/AFS Licence No: 238188 and regulated by Australian Securities and Investments Commission) and their investment banking affiliates. J.P. Morgan Securities plc is exempt from the licensing provisions of the Financial and Intermediary Services Act, 2002 (South Africa).
For Brazil: Ombudsman J.P. Morgan: 0800-7700847 / [email protected]
For Australia: This material is issued and distributed by J.P. Morgan Australia Limited (ABN 52 002 888 011/AFS Licence No: 238188) (regulated by ASIC) for the benefit of “wholesale clients” only. This material does not take into account the specific investment objectives, financial situation or particular needs of the recipient. The recipient of this material must not distribute it to any third party or outside Australia without the prior written consent of J.P. Morgan Australia Limited.
© 2017 JPMorgan Chase & Co. All rights reserved.